Galmed q3 loss per share $0.21

Galmed pharmaceuticals provides business update and reports third quarter 2019 financial results.q3 loss per share $0.21.q3 earnings per share estimate $-0.29 -- refinitiv ibes data.cash and cash equivalents, short-term deposits and marketable securities totaled $79.7 million as of sept 30, 2019.

GLMD Ratings Summary

GLMD Quant Ranking